Gregory A Gould
CIK 1252905 · Chief Financial Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.2K
Companies
4
Total Filings
54
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACONW | Chief Financial Officer | 50,000 | $0.02 | $1.2K | $0 | 2 | 2026-06-12 |
| NewAge, Inc. (NBEV) Delisted | Chief Financial Officer | 331,255 | $0.09 | $31.0K | $0 | 7 | 2021-07-07 |
| Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Chief Financial Officer | — | $0.18 | — | $0 | 2 | 2016-07-19 |
| SERACARE LIFE SCIENCES INC (SRLS) Delisted | Interim CEO, CFO, Treas & Sec. | 0 | — | — | $0 | 17 | 2012-04-20 |
Recent Filings · Page 4 of 6
54 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-03-04 | — | Grant (A) | +2,500 | $0 | |
| 2012-12-04 | — | Grant (A) | +1,562 | $0 | |
| 2012-09-05 | — | Grant (A) | +3,246 | $0 | |
| 2012-06-04 | — | Grant (A) | — | $0 | |
| 2012-05-23 | — | Grant (A) | +3,743 | $0 | |
| 2012-04-20 | SERACARE LIFE SCIENCES INC (SRLS) Delisted | Disp (D) | −237,844 | $0 | EDGAR |
| 2012-03-09 | SERACARE LIFE SCIENCES INC (SRLS) Delisted | Tax (F) | −1,119 | -$4.4K | EDGAR |
| 2012-02-02 | SERACARE LIFE SCIENCES INC (SRLS) Delisted | Grant (A) | +1,492 | $0 | EDGAR |
| 2012-01-04 | SERACARE LIFE SCIENCES INC (SRLS) Delisted | Grant (A) | +1,613 | $0 | EDGAR |
| 2011-12-09 | SERACARE LIFE SCIENCES INC (SRLS) Delisted | Tax (F) | −3,964 | -$11.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.